Clinical Trials on Dupuytren Contracture in Australia

Total 6 results

Endo Pharmaceuticals

Completed

Non-US Study of AA4500 (XIAFLEX™, Proposed Name) in the Treatment of Advanced Dupuytren's Disease (CORD-II)

Advanced Dupuytren's Disease

Australia
Endo Pharmaceuticals

Completed

Administration of Two Injections for Multiple Dupuytren's Contractures

Dupuytren's Contracture

United States, Australia
Endo Pharmaceuticals

Completed

Phase 2a Dose-Ranging Study to Evaluate Safety and Effectiveness of AA4500 in Treatment of Dupuytren's Disease Nodules

Dupuytren's Disease

United States, Australia
Endo Pharmaceuticals

Completed

Retreatment of Recurrent Dupuytren's Contractures

Dupuytren's Disease

United States, Australia, Sweden, United Kingdom
Endo Pharmaceuticals

Completed

Longterm Observational Study in Subjects Treated With AA4500 in AUX-CC-854, 856, 857, 858 & 859

Dupuytren's Disease

United States, Denmark, Australia, Finland, Sweden, United Kingdom
Medical University Innsbruck

Completed

Experimental and Clinical Investigation of the Implant Surface Roughness Reduction Effect on Early-stage Fibrosis

Wounds and Injuries | Foreign-Body Reaction | Tissue Expander Disorder | Capsular Contracture Associated With Implant

Austria

3

Subscribe